Daniel Vasella
Daniel Vasella
Daniel Lucius Vasella, M.D.is a medical doctor, author, and executive who served as CEO and chairman of the Swiss pharmaceutical company Novartis AG, the world's fifth largest drug company. During his tenure the Novartis shares declined 10%, below the industry...
although areas discussed explore hope time
At present, no collaboration has been discussed with Roche management, although we hope that over time we will be able to explore areas of collaboration.
anticipate dynamic fourth full growth looking operating quarter resulting sales softer solid somewhat third
Looking ahead, we anticipate a somewhat softer third quarter and, again, a more dynamic fourth quarter resulting in mid-single-digit sales growth... and solid operating growth for the full year,
growth increased investment key level marketing percent priority resulted sales
Our increased level of investment in marketing and sales, with the priority on key growth drivers, resulted in a sales growth of 21 percent in Pharmaceuticals in the U.S.,